Filing Flows › Bioventus (BVS) › Free cash flow
Bioventus (BVS) free cash flow by quarter
Bioventus' free cash flow was $20.3M in Q3 2026 (third quarter 2026), +7% from Q2 2026. Over the last 6 quarters it ranged from $8.4M (Q1 2026) to $37.4M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $20.3M | +7% | -31% |
| Q2 2026 | $18.9M | +126% | -25% |
| Q1 2026 | $8.4M | -78% | — |
| Q4 2025 | $37.4M | +26% | — |
| Q3 2025 | $29.6M | +17% | — |
| Q2 2025 | $25.3M | — | — |
Q3 2026 at a glance
Bioventus, Q3 2026: revenue $142M (+3% year over year), operating margin 6.8%, net earnings $6.0M, operating cash flow $20.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bioventus' free cash flow?
Bioventus' free cash flow was $20.3M in Q3 2026 (third quarter 2026), +7% from Q2 2026.
How has Bioventus' free cash flow changed?
Over the last 6 quarters it ranged from $8.4M (Q1 2026) to $37.4M (Q4 2025).